Autoimmunity risk- and protection-associated IL7RA genetic variants differentially affect soluble and membrane IL-7Rα expression. (February 2019)
- Record Type:
- Journal Article
- Title:
- Autoimmunity risk- and protection-associated IL7RA genetic variants differentially affect soluble and membrane IL-7Rα expression. (February 2019)
- Main Title:
- Autoimmunity risk- and protection-associated IL7RA genetic variants differentially affect soluble and membrane IL-7Rα expression
- Authors:
- Lundtoft, Christian
Seyfarth, Julia
Oberstrass, Sonja
Rosenbauer, Joachim
Baechle, Christina
Roden, Michael
Holl, Reinhard W.
Mayatepek, Ertan
Kummer, Sebastian
Meissner, Thomas
Jacobsen, Marc - Abstract:
- Abstract: Interleukin-7 receptor α-chain ( IL7RA ) haplotypes are associated with susceptibility to autoimmune diseases including type 1 diabetes (T1D). Previous studies found lower soluble IL-7Rα (sIL-7Rα) serum levels of the protection-associated IL7RA haplotype assumed to reduce IL-7 availability for self-reactive T cells. Also, a risk-associated IL7RA haplotype is accompanied by lower sIL-7Rα serum concentrations but no underlying mechanisms have been described and the causative polymorphism remains unknown. Here, we characterized functional implications of the nonsynonymous rs1494558 (Thr66Ile), which tags the protection-associated IL7RA haplotype, in HEK293T cells and serum samples of T1D patients with different haplotype carriers. Influence of risk- and protection-associated haplotypes on IL-7Rα was analyzed. The risk-associated Ile66 variant affected gel mobility and impaired secretion of the sIL-7Rα as well as expression of the membrane-associated (m)IL-7Rα in HEK293T cells. Serum sIL-7Rα analyses confirmed differential gel mobility of the Ile66 variant and found decreased sIL-7Rα serum levels of T1D patients carrying the Ile66-tagged haplotype. Differences in glycosylation were not causative for differential mobility but enhanced the effects on impaired secretion. Comparison of protection- and risk-associated haplotypes in a cell line-based in vitro model identified dominant effects of the protective haplotype tagged by rs6897932 (Ile244) on mIL-7Rα expression,Abstract: Interleukin-7 receptor α-chain ( IL7RA ) haplotypes are associated with susceptibility to autoimmune diseases including type 1 diabetes (T1D). Previous studies found lower soluble IL-7Rα (sIL-7Rα) serum levels of the protection-associated IL7RA haplotype assumed to reduce IL-7 availability for self-reactive T cells. Also, a risk-associated IL7RA haplotype is accompanied by lower sIL-7Rα serum concentrations but no underlying mechanisms have been described and the causative polymorphism remains unknown. Here, we characterized functional implications of the nonsynonymous rs1494558 (Thr66Ile), which tags the protection-associated IL7RA haplotype, in HEK293T cells and serum samples of T1D patients with different haplotype carriers. Influence of risk- and protection-associated haplotypes on IL-7Rα was analyzed. The risk-associated Ile66 variant affected gel mobility and impaired secretion of the sIL-7Rα as well as expression of the membrane-associated (m)IL-7Rα in HEK293T cells. Serum sIL-7Rα analyses confirmed differential gel mobility of the Ile66 variant and found decreased sIL-7Rα serum levels of T1D patients carrying the Ile66-tagged haplotype. Differences in glycosylation were not causative for differential mobility but enhanced the effects on impaired secretion. Comparison of protection- and risk-associated haplotypes in a cell line-based in vitro model identified dominant effects of the protective haplotype tagged by rs6897932 (Ile244) on mIL-7Rα expression, whereas the risk haplotype mainly affected the sIL-7Rα. This study identified novel functional effects of the Ile66 IL7RA variant and characterized features of autoimmunity risk- and protection-associated haplotypes. The findings add to our understanding of how these haplotypes regulate sIL-7Rα and mIL-7Rα expression in T cells causing differential susceptibility to autoimmune diseases. Graphical abstract: Highlights: The autoimmunity risk-associated IL7RA Ile66 variant impairs secretion of sIL-7Rα. Type 1 diabetes patients with Ile66 have lower soluble IL-7Rα serum levels. Conformational changes induced by Ile66 were glycosylation independent. Risk- and protection- (Ile244) associated haplotypes affect sIL-7Rα secretion. Membrane IL-7Rα expression was only increased for the IL7RA Ile244 allele. … (more)
- Is Part Of:
- Journal of autoimmunity. Volume 97(2019)
- Journal:
- Journal of autoimmunity
- Issue:
- Volume 97(2019)
- Issue Display:
- Volume 97, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 97
- Issue:
- 2019
- Issue Sort Value:
- 2019-0097-2019-0000
- Page Start:
- 40
- Page End:
- 47
- Publication Date:
- 2019-02
- Subjects:
- T cells -- IL-7 -- IL-7 receptor α-chain -- rs1494558 -- rs6897932
Autoimmunity -- Periodicals
Autoimmune diseases -- Periodicals
Autoantibodies -- Periodicals
Autoimmune Diseases -- Periodicals
Auto-immunité -- Périodiques
Maladies auto-immunes -- Périodiques
Electronic journals
616.978005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08968411 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/08968411 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jaut.2018.10.003 ↗
- Languages:
- English
- ISSNs:
- 0896-8411
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4949.555000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9571.xml